Tag Archives: CureVac GmbH

RNActive® Vaccines Complexed to Protamine

Dear all, numerous research activities with a strong focus on nucleic acid chemistry-based therapeutics have to face the same problem: how to transport these poly-anionic compounds into the cell? The most applied technology is the complexation of siRNA (1), microRNA … Continue reading

Posted in Binding Assay Blog History | Tagged , , , , , | Leave a comment

Upcoming Drugs: In Vivo Gene Transfer With Messenger RNA

Dear all, the world of nucleic acid therapeutics is fascinating. A novel advancement in this field develops messenger RNA as a tool for in vivo gene transfer, either for antigen expression in vaccination procedures, or to improve, and even supplement … Continue reading

Posted in Binding Assay Blog History | Tagged , , | Leave a comment